Connect with us

Finance

China says it’s willing to cooperate with the U.S. on fentanyl

Published

on

China’s and U.S.’ flags are seen printed on paper in this illustration taken January 27, 2022. 

Dado Ruvic | Reuters

BEIJING — China is willing to do more to address White House concerns about illicit fentanyl trade, but it will be “a different thing” if ongoing debate over the drug facilitates more U.S. tariffs on the world’s second largest economy, an official from the Chinese Ministry of Foreign Affairs told reporters Wednesday.

Washington should have “said a big thank you” to China on what it has done to restrict fentanyl trade in the U.S., the official said via an official English translation, claiming the White House did not appreciate the effort and instead raised duties on Chinese goods twice this year over the drug.

Since taking office in January, U.S. President Donald Trump has increased tariffs on Chinese goods by 20% on the basis of the country’s alleged role in the U.S. fentanyl crisis. The addictive drug, precursors to which are mostly produced in China and Mexico, has led to tens of thousands of overdose deaths each year in the U.S.

The White House did not immediately respond to a CNBC request for comment.

Earlier this month, the Chinese government published a white paper to publicize its efforts to curtail the production and export of fentanyl precursors over the last few years. The official did not respond directly to a question on whether China would stop its recent efforts to restrict such trade.

Under the Biden administration, the U.S. and China had said fentanyl was one of the few areas in which the two countries could cooperate. Both sides held dedicated talks in Beijing last year on the topic.

Trump's trade strategy is about restructuring economic relationships, says China Beige Book CEO

Trump indicated earlier this year that he could also use tariffs as a way to pressure China into forcing Beijing-based ByteDance to sell TikTok, which is running against an early April deadline to remain available in the U.S.

Trump had emphasized tariffs as a way to reduce the U.S. trade deficit with China during his first presidency. Just before the onset of the Covid-19 pandemic, the two sides reached a “Phase One” trade agreement requiring Beijing to increase its purchases of U.S. goods. U.S. data shows that the trade deficit with China narrowed to $295.4 billion in 2024, from $346.83 billion in 2016, just ahead of Trump’s first mandate.

But differences on trade have continued since the January start of the White House leader’s second mandate. The average effective U.S. tariff rate on Chinese goods is now set to hit 33%, up from around 13% before Trump began his latest term, according to estimates from Nomura’s Chief China Economist Ting Lu.

Beijing has responded to the latest U.S. tariffs with targeted duties on energy and agriculture products, while tightening restrictions on exports of critical minerals that the U.S. needs. China’s Ministry of Commerce has also added several U.S. companies, mostly in aerospace or defense, to lists that limit their ability to do business with China.

The Ministry of Foreign Affairs official said Wednesday that China’s countermeasures were “legitimate actions” to protect its own interests.

Allianz estimates the additional 20% U.S. tariffs on Chinese goods would hit China’s GDP growth by 0.6 percentage points this year and next. But the firm still expects the Chinese economy to grow by 4.6% this year and 4.2% in 2026, based on the assumption that stimulus can mitigate the tariff impact.

“I would tend to say the retaliation is not so strong, maybe leaving room for negotiations,” Francoise Huang, senior economist for Asia-Pacific and global trade at Allianz Trade, said in a CNBC interview last week.

Continue Reading

Finance

Stocks making the biggest moves midday: WOOF, TSLA, CRCL, LULU

Published

on

Continue Reading

Finance

Swiss government proposes tough new capital rules in major blow to UBS

Published

on

A sign in German that reads “part of the UBS group” in Basel on May 5, 2025.

Fabrice Coffrini | AFP | Getty Images

The Swiss government on Friday proposed strict new capital rules that would require banking giant UBS to hold an additional $26 billion in core capital, following its 2023 takeover of stricken rival Credit Suisse.

The measures would also mean that UBS will need to fully capitalize its foreign units and carry out fewer share buybacks.

“The rise in the going-concern requirement needs to be met with up to USD 26 billion of CET1 capital, to allow the AT1 bond holdings to be reduced by around USD 8 billion,” the government said in a Friday statement, referring to UBS’ holding of Additional Tier 1 (AT1) bonds.

The Swiss National Bank said it supported the measures from the government as they will “significantly strengthen” UBS’ resilience.

“As well as reducing the likelihood of a large systemically important bank such as UBS getting into financial distress, this measure also increases a bank’s room for manoeuvre to stabilise itself in a crisis through its own efforts. This makes it less likely that UBS has to be bailed out by the government in the event of a crisis,” SNB said in a Friday statement.

‘Too big to fail’

UBS has been battling the specter of tighter capital rules since acquiring the country’s second-largest bank at a cut-price following years of strategic errors, mismanagement and scandals at Credit Suisse.

The shock demise of the banking giant also brought Swiss financial regulator FINMA under fire for its perceived scarce supervision of the bank and the ultimate timing of its intervention.

Swiss regulators argue that UBS must have stronger capital requirements to safeguard the national economy and financial system, given the bank’s balance topped $1.7 trillion in 2023, roughly double the projected Swiss economic output of last year. UBS insists it is not “too big to fail” and that the additional capital requirements — set to drain its cash liquidity — will impact the bank’s competitiveness.

At the heart of the standoff are pressing concerns over UBS’ ability to buffer any prospective losses at its foreign units, where it has, until now, had the duty to back 60% of capital with capital at the parent bank.

Higher capital requirements can whittle down a bank’s balance sheet and credit supply by bolstering a lender’s funding costs and choking off their willingness to lend — as well as waning their appetite for risk. For shareholders, of note will be the potential impact on discretionary funds available for distribution, including dividends, share buybacks and bonus payments.

“While winding down Credit Suisse’s legacy businesses should free up capital and reduce costs for UBS, much of these gains could be absorbed by stricter regulatory demands,” Johann Scholtz, senior equity analyst at Morningstar, said in a note preceding the FINMA announcement. 

“Such measures may place UBS’s capital requirements well above those faced by rivals in the United States, putting pressure on returns and reducing prospects for narrowing its long-term valuation gap. Even its long-standing premium rating relative to the European banking sector has recently evaporated.”

The prospect of stringent Swiss capital rules and UBS’ extensive U.S. presence through its core global wealth management division comes as White House trade tariffs already weigh on the bank’s fortunes. In a dramatic twist, the bank lost its crown as continental Europe’s most valuable lender by market capitalization to Spanish giant Santander in mid-April.

Continue Reading

Finance

TSLA, CRCL, AVGO, LULU and more

Published

on

Continue Reading

Trending